CD274 and neoplasm: PD-L1 (clone 22C3) immunostaining was positive in approximately 20% of the tumor cells, albeit membranous immunostaining was weak, mostly; the tumor-infiltrating lymphocytes and histiocytes were PD-L1 positive throughout.